HomeInsightsMarket Capitalization

Market Capitalization of Aurobindo Pharma Ltd

Market Capitalization of Aurobindo Pharma Ltd

stocks purchased

₹ 1.7 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

12.3 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

MARKETCAP

₹ 79131.01 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Aurobindo Pharma Ltd is ₹ 79131 crore as of 07 Nov 24.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 46052 crore on March 2019 to ₹ 63835 crore on March 2024 . This represents a CAGR of 5.59% over 6 years. .
  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1350 as of 07 Nov 15:30.
  • The Dividend Payouts of Aurobindo Pharma Ltd changed from ₹ 1.5 on Nov 17, 2021 to ₹ 1.5 on Feb 20, 2024 . This represents a CAGR of 0.00% over 6 years. .

Historical Market Cap of Aurobindo Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Aurobindo Pharma Ltd

No data available

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

PRICE

₹ 1350.5

-44.15 (-3.17%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241350.5
06 Nov 20241394.65
05 Nov 20241396.1
04 Nov 20241407.25
01 Nov 20241401.1
31 Oct 20241396
30 Oct 20241404.7
29 Oct 20241412.65
28 Oct 20241433.85
25 Oct 20241427.15

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Aurobindo Pharma Ltd

No data available

No data available

Historical P/E Ratio of Aurobindo Pharma Ltd

No data available

* All values are in %

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Aurobindo Pharma Ltd

No data available

* All values are in

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma to table results

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 9 Novembe...

Read more

02 Nov 202412:52

News

Aurobindo Pharma completes acquisition of balance 49% stake in GLS Pharma

Aurobindo Pharma has completed the acquisition of balance 49% stake in its subsidiary, GLS...

Read more

25 Oct 202419:30

News

Aurobindo Pharma Ltd spurts 1.19%, up for fifth straight session

Aurobindo Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs...

Read more

09 Oct 202413:00

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV

Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:19

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'

Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:21

News

Auro Pharma gets USFDA nod for urinary tract infections drug.

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Oct 202414:58

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Aurobindo Pharma Ltd Market Cap

What is the market cap of Aurobindo Pharma Ltd?

As of November 8, 2024, Aurobindo Pharma Ltd has a market capitalization of ₹79131.01, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aurobindo Pharma Ltd's market capitalization?

Aurobindo Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aurobindo Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aurobindo Pharma Ltd's market capitalization change?

Aurobindo Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*